Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGI004 (transdermal mecamylamine) for control of chemotherapy-induced diarrhoea
2007-004291-39Phase 2Completed
- Sponsor
- AGI Therapeutics plc
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diarrhea comparing Transdermal mecamylamine (AGI004) with Placebo patch (2 arms). Primary endpoint: Primary efficacy endpoints. Started Nov 2007; status: completed.
02
Drugs
mecamylamine
03
Conditions
diarrhea
Beyond the preview
Go deeper on 2007-004291-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004291-39.